WeBD.Tokyo
  • Home
  • Insights
  • About
  • Contact
  • cdmo.jp
  • LinkedIn

October 2024

Digitizing BD

Preview: Comprehensive list of Pharmaceutical companies in Japan

For non-Japanese biopharmaceutical companies looking to enter the Japanese market, the first challenge is often finding a comprehensive list of biopharma companies in Japan. While big names like Takeda or Astellas are well-known globally, many smaller, innovative players remain under the radar. These small-to-mid-size companies can offer unique partnership opportunities, Read more

By md, 1 yearOctober 1, 2024 ago

Recent Posts

  • Launching cdmo.jp — A Japan-first platform to showcase differentiated CDMO technologies
  • When Yes Means No: Decoding Japanese Tatemae in Pharma Business
  • BioJapan 2025: A Gentle Reminder on CDMO & Biotech Sales —Why Trust Matters More Than Pushy Tactics
  • Why Replies Are Hard to Get on BioJapan’s Partnering Platform
  • Before You Hit “Send” on That Quote — The One Move That Saves Deals in Japan

Recent Comments

No comments to show.

Archives

  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • March 2025
  • October 2024

Categories

  • Digitizing BD
  • Japan Market Entry
  • Just for fun
  • Regulatory

WeBD.Tokyo is provided through a legal entity:
Dohi Inc. (Kanagawa, Japan)
# Corporate ID: 7021001076723


Hestia | Developed by ThemeIsle